Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: OrganiGram Holdings Inc

Market Cap 210M 150M 130M 120M 112M 14.28B 213M 1.41B 550M 6.95B 564M 552M 24.07B P/E Ratio 2026 *
11.5x
P/E Ratio 2027 * 37.3x
Enterprise Value 210M 150M 130M 120M 112M 14.28B 213M 1.41B 550M 6.95B 564M 552M 24.07B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.48x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 12/01/2021
Director/Board Member 68 25/02/2020
Director/Board Member - 15/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 150M
+4.29%+1.19%+45.30%+71.72% 120M
+1.92%-3.64%+70.97%-25.35% 108M
-3.81%-6.15%+64.24%+3.23% 95.12M
Average +1.78%-2.86%+60.17%+16.53% 107.66M
Weighted average by Cap. +2.26%-2.58%+59.43%+19.22%

Financials

2026 *2027 *
Net sales 340M 243M 210M 194M 181M 23.12B 345M 2.29B 891M 11.25B 913M 893M 38.96B 441M 316M 273M 251M 235M 30.01B 448M 2.97B 1.16B 14.61B 1.18B 1.16B 50.58B
Net income 18.88M 13.52M 11.68M 10.76M 10.07M 1.29B 19.17M 127M 49.54M 626M 50.74M 49.66M 2.17B 6.53M 4.68M 4.04M 3.72M 3.48M 445M 6.63M 43.96M 17.14M 216M 17.55M 17.18M 749M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!